Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.53
+0.55 (6.89%)
At close: Jun 26, 2026, 4:00 PM EDT
8.51
-0.02 (-0.19%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Emergent BioSolutions stock has a target of 12, which predicts an increase of 40.68% from the current stock price of 8.53.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Emergent BioSolutions stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +40.68% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
733.05M
from 742.90M
Decreased by -1.33%
Revenue Next Year
892.00M
from 733.05M
Increased by 21.68%
EPS This Year
0.95
from 1.53
Decreased by -37.91%
EPS Next Year
-0.96
from 0.95
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 746.1M | 892.0M | |
| Avg | 733.1M | 892.0M | |
| Low | 720.0M | 892.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.4% | 21.7% | |
| Avg | -1.3% | 21.7% | |
| Low | -3.1% | 21.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 0.95 | -0.96 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -37.9% | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.